Why the study?
Does cardiac alpha-actin (ACTC) expression rescue survival and muscle function in Acta1 knockout mice?
Population
Acta1 knockout mice (which normally die by 9 days after birth)
Comparison
Expression of cardiac alpha-actin via transgenic… vs Acta1 knockout mice without ACTC transgene
Design
Preclinical
Follow-up
to old age
Key result
Transgenic expression of cardiac alpha-actin (ACTC) rescued Acta1 knockout mice from early postnatal death, enabling survival to old age without impairment in skeletal muscle function.
Authors
Loading...
Extends evidence for actin isoform interchangeability; leaves open therapeutic translation to human ACTA1 myopathies.
Does cardiac alpha-actin (ACTC) expression rescue survival and muscle function in Acta1 knockout mice?
Cardiac alpha-actin (ACTC) can functionally replace skeletal muscle alpha-actin (ACTA1) in postnatal skeletal muscle, suggesting ACTC reactivation as a potential therapy for ACTA1 congenital myopathies.
Ravenscroft et al. (2009) studied ACTA1 congenital myopathies. Cardiac alpha-actin (ACTC) transgene vs. Acta1 knockout mice (expected to die by 9 days after birth) was evaluated on Survival and skeletal muscle function (grip strength, rotarod, locomotor activity). Transgenic expression of cardiac alpha-actin (ACTC) rescued Acta1 knockout mice from early postnatal death, enabling survival to old age without impairment in skeletal muscle function.